目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 33)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 CLINICAL TRIAL IMAGING MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 37)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 CLINICAL TRIAL IMAGING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 CLINICAL TRIAL IMAGING MARKET: BOTTOM-UP APPROACH
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 CLINICAL TRIAL IMAGING MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 GROWTH RATE ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
2.9 COVID-19 HEALTH ASSESSMENT
2.10 COVID-19 ECONOMIC ASSESSMENT
2.10.1 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.10.2 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE CLINICAL TRIAL IMAGING MARKET

3 EXECUTIVE SUMMARY (Page No. - 49)
FIGURE 10 CLINICAL TRIAL IMAGING MARKET, BY PRODUCT AND SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 11 CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2021 VS. 2026 (USD MILLION)
FIGURE 12 CLINICAL TRIAL IMAGING MARKET, BY THERAPEUTIC AREA, 2021 VS. 2026 (USD MILLION)
FIGURE 13 CLINICAL TRIAL IMAGING MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 CLINICAL TRIAL IMAGING MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 53)
4.1 CLINICAL TRIAL IMAGING MARKET OVERVIEW
FIGURE 15 INCREASE IN R&D SPENDING TO DRIVE MARKET GROWTH
4.2 CLINICAL TRIAL IMAGING MARKET SHARE, BY PRODUCT & SERVICE, 2021 VS. 2026
FIGURE 16 SERVICES WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 CLINICAL TRIAL IMAGING MARKET SHARE, BY MODALITY, 2021 VS. 2026
FIGURE 17 COMPUTED TOMOGRAPHY TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4 CLINICAL TRIAL IMAGING MARKET SHARE, BY THERAPEUTIC AREA, 2021 VS. 2026
FIGURE 18 ONCOLOGY IS THE LARGEST SEGMENT IN THE CLINICAL TRIAL IMAGING MARKET BY THERAPEUTIC AREA
4.5 CLINICAL TRIAL IMAGING MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 19 PHARMACEUTICAL COMPANIES FORM THE LARGEST END USERS OF THE CLINICAL TRIAL IMAGING MARKET
4.6 CLINICAL TRIAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE CLINICAL TRIAL IMAGING MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 56)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 CLINICAL TRIAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing R&D spending
5.2.1.2 Growth in the pharmaceutical and biotechnology industries
5.2.1.3 Increasing number of CROs
5.2.2 RESTRAINTS
5.2.2.1 High implementation cost of imaging systems
5.2.3 OPPORTUNITIES
5.2.3.1 Developing countries
5.2.3.2 Development of innovative imaging modalities, contrast agents, molecular probes, and radiopharmaceuticals
5.2.4 CHALLENGES
5.2.4.1 High cost of clinical trials
5.3 IMPACT OF COVID-19 ON THE CLINICAL TRIAL IMAGING MARKET
5.4 PRICING ANALYSIS
TABLE 1 PRICES OF CLINICAL TRIAL IMAGING PRODUCTS (2021)
5.5 PATENT ANALYSIS
5.6 TRADE ANALYSIS
5.6.1 TRADE ANALYSIS FOR X-RAY APPARATUSES
TABLE 2 IMPORT DATA FOR X-RAY APPARATUSES, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 3 EXPORT DATA FOR X-RAY APPARATUSES, BY COUNTRY, 2016-2020 (USD MILLION)
5.6.2 TRADE ANALYSIS FOR CT APPARATUSES
TABLE 4 IMPORT DATA FOR CT APPARATUSES, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 5 EXPORT DATA FOR CT APPARATUSES, BY COUNTRY, 2016-2020 (USD MILLION)
5.7 VALUE CHAIN ANALYSIS
FIGURE 22 MAJOR VALUE IS ADDED DURING THE DEVELOPMENT AND PROCUREMENT PHASES
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 23 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.9 ECOSYSTEM ANALYSIS OF THE CLINICAL TRIAL IMAGING MARKET
FIGURE 24 CLINICAL TRIAL IMAGING MARKET: ECOSYSTEM ANALYSIS
5.9.1 ROLE IN THE ECOSYSTEM
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 CLINICAL TRIAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF BUYERS
5.10.4 BARGAINING POWER OF SUPPLIERS
5.10.5 DEGREE OF COMPETITION
5.11 PESTLE ANALYSIS
5.12 REGULATORY LANDSCAPE
5.12.1 NORTH AMERICA
5.12.1.1 US
5.12.1.2 Canada
5.12.2 EUROPE
5.12.3 ASIA PACIFIC
5.12.3.1 Japan
5.12.3.2 India
5.12.3.3 China
5.12.4 LATIN AMERICA
5.12.4.1 Brazil
5.12.4.2 Mexico
5.12.5 MIDDLE EAST
5.12.6 AFRICA
5.13 TECHNOLOGY ANALYSIS
5.14 DISRUPTIVE TECHNOLOGIES IN THE CLINICAL TRIAL IMAGING MARKET
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR THE CLINICAL TRIAL IMAGING MARKET
FIGURE 25 REVENUE SHIFT FOR THE CLINICAL TRIAL IMAGING MARKET

6 CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE (Page No. - 71)
6.1 INTRODUCTION
TABLE 7 CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 8 CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
6.2 SERVICES
TABLE 9 CLINICAL TRIAL IMAGING SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 10 CLINICAL TRIAL IMAGING SERVICES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 11 CLINICAL TRIAL IMAGING SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 12 CLINICAL TRIAL IMAGING SERVICES MARKET, BY REGION, 2020-2026 (USD MILLION)
6.2.1 OPERATIONAL IMAGING SERVICES
6.2.1.1 The rising number of CROs supports the growth of this segment
FIGURE 26 INDUSTRY INSIGHTS ON OPERATIONAL IMAGING SERVICES
TABLE 13 OPERATIONAL IMAGING SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 14 OPERATIONAL IMAGING SERVICES MARKET, BY REGION, 2020-2026 (USD MILLION)
6.2.2 READ ANALYSIS SERVICES
6.2.2.1 Increased number of clinical trials is the major factor supporting the growth of this segment
TABLE 15 READ ANALYSIS SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 16 READ ANALYSIS SERVICES MARKET, BY REGION, 2020-2026 (USD MILLION)
6.2.3 SYSTEM & TECHNICAL SUPPORT SERVICES
6.2.3.1 Need for continuous technical support to drive this segment
TABLE 17 SYSTEM & TECHNICAL SUPPORT SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 18 SYSTEM & TECHNICAL SUPPORT SERVICES MARKET, BY REGION, 2020-2026 (USD MILLION)
6.2.4 TRIAL DESIGN & CONSULTING SERVICES
6.2.4.1 Rising R&D spending and support for clinical trials will prompt companies to outsource trial design processes
TABLE 19 TRIAL DESIGN & CONSULTING SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 20 TRIAL DESIGN & CONSULTING SERVICES MARKET, BY REGION, 2020-2026 (USD MILLION)
6.3 SOFTWARE
6.3.1 HIGH EFFICIENCY AND COST-SAVING BENEFITS OF SOFTWARE SUPPORT ITS ADOPTION
TABLE 21 CLINICAL TRIAL IMAGING SOFTWARE MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 22 CLINICAL TRIAL IMAGING SOFTWARE MARKET, BY REGION, 2020-2026 (USD MILLION)

7 CLINICAL TRIAL IMAGING MARKET, BY MODALITY (Page No. - 80)
7.1 INTRODUCTION
TABLE 23 CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 24 CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
7.2 COMPUTED TOMOGRAPHY
7.2.1 QUICK RESULTS AND NO VISIBLE SIDE-EFFECTS DRIVE THE ADOPTION OF CT
TABLE 25 CLINICAL TRIAL IMAGING MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2016-2019 (USD MILLION)
TABLE 26 CLINICAL TRIAL IMAGING MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2020-2026 (USD MILLION)
7.3 MAGNETIC RESONANCE IMAGING
7.3.1 INCREASING ADOPTION OF MRI IN ONCOLOGICAL TRIALS AND STUDIES TO DRIVE MARKET GROWTH
TABLE 27 CLINICAL TRIAL IMAGING MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2016-2019 (USD MILLION)
TABLE 28 CLINICAL TRIAL IMAGING MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2020-2026 (USD MILLION)
7.4 ULTRASOUND
7.4.1 ULTRASOUND IMAGING IS SAFER THAN CT AND MRI IMAGING
TABLE 29 CLINICAL TRIAL IMAGING MARKET FOR ULTRASOUND, BY REGION, 2016-2019 (USD MILLION)
TABLE 30 CLINICAL TRIAL IMAGING MARKET FOR ULTRASOUND, BY REGION, 2020-2026 (USD MILLION)
7.5 POSITRON EMISSION TOMOGRAPHY
7.5.1 PET IS A PART OF NUCLEAR MEDICINE IMAGING
TABLE 31 CLINICAL TRIAL IMAGING MARKET FOR PET, BY REGION, 2016-2019 (USD MILLION)
TABLE 32 CLINICAL TRIAL IMAGING MARKET FOR PET, BY REGION, 2020-2026 (USD MILLION)
7.6 X-RAY
7.6.1 X-RAY IS MOST COMMONLY USED IN BONE, CHEST, AND DENTAL IMAGING
TABLE 33 CLINICAL TRIAL IMAGING MARKET FOR X-RAY, BY REGION, 2016-2019 (USD MILLION)
TABLE 34 CLINICAL TRIAL IMAGING MARKET FOR X-RAY, BY REGION, 2020-2026 (USD MILLION)
7.7 ECHOCARDIOGRAPHY
7.7.1 ECHO-DOPPLER PARAMETERS ARE CONSIDERED ACCEPTABLE AS A PROOF OF CONCEPT OF TREATMENT IN PHASE-II TRIALS
TABLE 35 CLINICAL TRIAL IMAGING MARKET FOR ECHOCARDIOGRAPHY, BY REGION, 2016-2019 (USD MILLION)
TABLE 36 CLINICAL TRIAL IMAGING MARKET FOR ECHOCARDIOGRAPHY, BY REGION, 2020-2026 (USD MILLION)
7.8 OTHER MODALITIES
TABLE 37 CLINICAL TRIAL IMAGING MARKET FOR OTHER MODALITIES, BY REGION, 2016-2019 (USD MILLION)
TABLE 38 CLINICAL TRIAL IMAGING MARKET FOR OTHER MODALITIES, BY REGION, 2020-2026 (USD MILLION)

8 CLINICAL TRIAL IMAGING MARKET, BY THERAPEUTIC AREA (Page No. - 91)
8.1 INTRODUCTION
TABLE 39 CLINICAL TRIAL IMAGING MARKET, BY THERAPEUTIC AREA, 2016-2019 (USD MILLION)
TABLE 40 CLINICAL TRIAL IMAGING MARKET, BY THERAPEUTIC AREA, 2016-2019 (USD MILLION)
TABLE 42 CLINICAL TRIAL IMAGING MARKET FOR ONCOLOGY, BY REGION, 2020-2026 (USD MILLION)
8.3 INFECTIOUS DISEASES
8.3.1 RISING DRUG DISCOVERY ACTIVITY SUPPORTS MARKET GROWTH
TABLE 43 CLINICAL TRIAL IMAGING MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016-2019 (USD MILLION)
TABLE 44 CLINICAL TRIAL IMAGING MARKET FOR INFECTIOUS DISEASES, BY REGION, 2020-2026 (USD MILLION)
8.4 NEUROLOGY
8.4.1 GROWING INVESTMENTS IN CNS DISORDER RESEARCH TO DRIVE SEGMENT GROWTH
TABLE 45 CLINICAL TRIAL IMAGING MARKET FOR NEUROLOGY, BY REGION, 2016-2019 (USD MILLION)
TABLE 46 CLINICAL TRIAL IMAGING MARKET FOR NEUROLOGY, BY REGION, 2020-2026 (USD MILLION)
8.5 CARDIOVASCULAR SYSTEM DISORDERS
8.5.1 HIGH MORTALITY RATE OF CVD HAS DRIVEN FOCUS ON THERAPEUTICS AND CLINICAL TRIALS
TABLE 47 CLINICAL TRIAL IMAGING MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2016-2019 (USD MILLION)
TABLE 48 CLINICAL TRIAL IMAGING MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2020-2026 (USD MILLION)
8.6 ENDOCRINOLOGY
8.6.1 RISING INCIDENCE OF DIABETES TO DRIVE MARKET GROWTH
TABLE 49 CLINICAL TRIAL IMAGING MARKET FOR ENDOCRINOLOGY, BY REGION, 2016-2019 (USD MILLION)
TABLE 50 CLINICAL TRIAL IMAGING MARKET FOR ENDOCRINOLOGY, BY REGION, 2020-2026 (USD MILLION)
8.7 IMMUNOLOGICAL DISORDERS
8.7.1 ALLERGIES, ASTHMA, AND AUTOIMMUNE DISEASES ARE HIGHLY COMMON AILMENTS GLOBALLY
TABLE 51 CLINICAL TRIAL IMAGING MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2016-2019 (USD MILLION)
TABLE 52 CLINICAL TRIAL IMAGING MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2020-2026 (USD MILLION)
8.8 OTHER THERAPEUTIC AREAS
TABLE 53 CLINICAL TRIAL IMAGING MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2016-2019 (USD MILLION)
TABLE 54 CLINICAL TRIAL IMAGING MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2020-2026 (USD MILLION)

9 CLINICAL TRIAL IMAGING MARKET, BY END USER (Page No. - 102)
9.1 INTRODUCTION
TABLE 55 CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 56 CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
9.2 PHARMACEUTICAL COMPANIES
9.2.1 INCREASING R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE MARKET GROWTH FOR THIS SEGMENT
TABLE 57 CLINICAL TRIAL IMAGING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2016-2019 (USD MILLION)
TABLE 58 CLINICAL TRIAL IMAGING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2020-2026 (USD MILLION)
9.3 BIOTECHNOLOGY COMPANIES
9.3.1 RISING R&D BUDGETS OF BIOTECH COMPANIES TO DRIVE GROWTH
TABLE 59 TOP BIOTECHNOLOGY INVESTMENT DEALS, 2019-2020
TABLE 60 CLINICAL TRIAL IMAGING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2019 (USD MILLION)
TABLE 61 CLINICAL TRIAL IMAGING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2026 (USD MILLION)
9.4 MEDICAL DEVICE MANUFACTURERS
9.4.1 INCREASING R&D SPENDING BY MEDICAL DEVICES MANUFACTURERS TO DRIVE MARKET GROWTH
TABLE 62 CLINICAL TRIAL IMAGING MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2016-2019 (USD MILLION)
TABLE 63 CLINICAL TRIAL IMAGING MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2020-2026 (USD MILLION)
9.5 CONTRACT RESEARCH ORGANIZATIONS
9.5.1 INCREASING TREND OF OUTSOURCING TO DRIVE MARKET GROWTH
TABLE 64 CLINICAL TRIAL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016-2019 (USD MILLION)
TABLE 65 CLINICAL TRIAL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020-2026 (USD MILLION)
9.6 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
9.6.1 INCREASING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH
TABLE 66 CLINICAL TRIAL IMAGING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2016-2019 (USD MILLION)
TABLE 67 CLINICAL TRIAL IMAGING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES MARKET, BY REGION, 2020-2026 (USD MILLION)
9.7 OTHER END USERS
TABLE 68 CLINICAL TRIAL IMAGING MARKET FOR OTHER END USERS, BY REGION, 2016-2019 (USD MILLION)
TABLE 69 CLINICAL TRIAL IMAGING MARKET FOR OTHER END USERS, BY REGION, 2020-2026 (USD MILLION)

10 CLINICAL TRIAL IMAGING MARKET, BY REGION (Page No. - 113)
10.1 INTRODUCTION
TABLE 70 CLINICAL TRIAL IMAGING MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 71 CLINICAL TRIAL IMAGING MARKET, BY REGION, 2020-2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET SNAPSHOT
TABLE 72 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 73 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 74 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 75 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 76 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 77 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 78 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 79 NORTH AMERICA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.2.1 US
10.2.1.1 Increased investment in the biopharmaceutical industry in the US to favor market growth
TABLE 80 US: PRODUCT APPROVALS IN THE CLINICAL TRIAL IMAGING SPACE
TABLE 81 US: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 82 US: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 83 US: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 84 US: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 85 US: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 86 US: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increase in per capita healthcare spending to drive the clinical trial imaging market in Canada
TABLE 87 CANADA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 88 CANADA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 89 CANADA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 90 CANADA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 91 CANADA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 92 CANADA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.3 EUROPE
TABLE 93 EUROPE: CLINICAL TRIAL IMAGING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 94 EUROPE: CLINICAL TRIAL IMAGING MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 95 EUROPE: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 96 EUROPE: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 97 EUROPE: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 98 EUROPE: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 99 EUROPE: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 100 EUROPE: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany is the largest & fastest-growing market for clinical trial imaging in Europe
TABLE 101 GERMANY: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 102 GERMANY: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 103 GERMANY: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 104 GERMANY: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 105 GERMANY: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 106 GERMANY: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.3.2 UK
10.3.2.1 Rising research investments to drive the market growth in the UK
TABLE 107 UK: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 108 UK: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 109 UK: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 110 UK: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 111 UK: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 112 UK: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Rising R&D expenditure to drive market growth in France
TABLE 113 FRANCE: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 114 FRANCE: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 115 FRANCE: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 116 FRANCE: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 117 FRANCE: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 118 FRANCE: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increase R&D spending on healthcare to drive market growth in this region
TABLE 119 ITALY: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 120 ITALY: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 121 ITALY: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 122 ITALY: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 123 ITALY: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 124 ITALY: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growth of pharmaceutical companies
TABLE 125 SPAIN: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 126 SPAIN: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 127 SPAIN: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 128 SPAIN: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 129 SPAIN: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 130 SPAIN: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 131 ROE: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 132 ROE: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 133 ROE: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 134 ROE: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 135 ROE: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 136 ROE: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET SNAPSHOT
TABLE 137 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 138 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 139 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 140 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 141 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 142 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 143 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 144 ASIA PACIFIC: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Increase in research spending to drive market growth
TABLE 145 CHINA: KEY MACROINDICATORS
TABLE 146 CHINA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 147 CHINA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 148 CHINA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 149 CHINA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 150 CHINA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 151 CHINA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising population and healthcare expenditure are favorable factors in Japan
TABLE 152 JAPAN: KEY MACROINDICATORS
TABLE 153 JAPAN: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 154 JAPAN: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 155 JAPAN: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 156 JAPAN: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 157 JAPAN: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 158 JAPAN: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increased investment in R&D to drive the adoption of clinical trial imaging
TABLE 159 INDIA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 160 INDIA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 161 INDIA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 162 INDIA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 163 INDIA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 164 INDIA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 165 ROAPAC: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 166 ROAPAC: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 167 ROAPAC: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 168 ROAPAC: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 169 ROAPAC: CLINICAL TRIAL IMAGING MARKET, BY END USER , 2016-2019 (USD MILLION)
TABLE 170 ROAPAC: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 INCREASING R&D DUE TO DISEASE OUTBREAKS TO SUPPORT MARKET GROWTH
TABLE 171 LATIN AMERICA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 172 LATIN AMERICA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 173 LATIN AMERICA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 174 LATIN AMERICA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 175 LATIN AMERICA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 176 LATIN AMERICA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASED FUNDING AND PARTNERSHIPS IN THE RESEARCH SECTOR TO PROPEL MARKET GROWTH
TABLE 177 MIDDLE EAST & AFRICA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 178 MIDDLE EAST AND AFRICA: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICE, 2020-2026 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2016-2019 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: CLINICAL TRIAL IMAGING MARKET, BY END USER, 2020-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 163)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE CLINICAL TRIAL IMAGING MARKET
TABLE 183 OVERVIEW OF STRATEGIES DEPLOYED BY KEY CLINICAL TRIAL IMAGING PRODUCT MANUFACTURING COMPANIES
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE CLINICAL TRIAL IMAGING MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 30 CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER (2020)
TABLE 184 CLINICAL TRIAL IMAGING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 31 CLINICAL TRIAL IMAGING MARKET: COMPANY EVALUATION QUADRANT, 2020
11.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2020)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 32 CLINICAL TRIAL IMAGING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
11.7 COMPETITIVE BENCHMARKING
FIGURE 33 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE CLINICAL TRIAL IMAGING MARKET
TABLE 185 COMPANY PRODUCT FOOTPRINT
TABLE 186 COMPANY GEOGRAPHICAL FOOTPRINT
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
TABLE 187 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
11.8.2 DEALS
TABLE 188 KEY DEALS

12 COMPANY PROFILES (Page No. - 172)
12.1 KEY PLAYERS
(Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats)*
12.1.1 ICON PLC.
TABLE 189 ICON PLC.: BUSINESS OVERVIEW
FIGURE 34 ICON PLC.: COMPANY SNAPSHOT (2020)
12.1.2 BIOTELEMETRY INC.
TABLE 190 BIOTELEMETRY INC.: BUSINESS OVERVIEW
FIGURE 35 PHILIPS GROUP: COMPANY SNAPSHOT (2020)
12.1.3 BIOMEDICAL SYSTEMS CORPORATION (A PART OF ERT CLINICAL)
TABLE 191 BIOMEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW
12.1.4 MEDPACE HOLDINGS INC.
TABLE 192 MEDPACE HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 36 MEDPACE HOLDINGS INC.: COMPANY SNAPSHOT (2020)
12.1.5 IXICO PLC.
TABLE 193 IXICO PLC.: BUSINESS OVERVIEW
FIGURE 37 IXICO PLC.: COMPANY SNAPSHOT (2020)
12.1.6 RESONANCE HEALTH LTD.
TABLE 194 RESONANCE HEALTH LTD.: BUSINESS OVERVIEW
FIGURE 38 RESONANCE HEALTH LTD.: COMPANY SNAPSHOT (2020)
12.1.7 RADIANT SAGE
TABLE 195 RADIANT SAGE: BUSINESS OVERVIEW
12.1.8 BIOCLINICA INC.
TABLE 196 BIOCLINICA: BUSINESS OVERVIEW
12.1.9 INTRINSIC IMAGING
TABLE 197 INTRINSIC IMAGING: BUSINESS OVERVIEW
12.1.10 CARDIOVASCULAR IMAGING TECHNOLOGIES
TABLE 198 CARDIOVASCULAR IMAGING TECHNOLOGIES: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 MEDICAL METRICS
12.2.2 PRISM CLINICAL IMAGING
12.2.3 BOSTON IMAGING CORE LAB
12.2.4 ANAGRAM 4 CLINICAL TRIALS
12.2.5 LYSCAUT MEDICAL IMAGING COMPANY
12.2.6 CALYX GROUP
12.2.7 BIOSPECTIVE
12.2.8 PROSCAN IMAGING
12.2.9 MICRON
12.2.10 IMAGING ENDPOINTS LI LLC.
12.2.11 PERSPECTUM
12.2.12 PHARMTRACE KLINISCHE ENTWICKLUNG
12.2.13 WORLDCARE CLINICAL

*Details on Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 198)
13.1 INDUSTRY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS